Phase I safety and immunogenicity studies of Peru 15, a live attenuated oral vaccine candidate for Vibrio cholerae 01 in Bangladeshi volunteers, both adults and children
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Qadri, Firdausi | - |
| dc.date.accessioned | 2014-02-18T08:01:21Z | - |
| dc.date.available | 2014-02-18T08:01:21Z | - |
| dc.date.issued | 2000 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/4912 | - |
| dc.format.extent | 2720943 bytes | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | ICDDRB Research Protocol | en |
| dc.relation.ispartofseries | no. 2000-027 | en |
| dc.subject | Clinical Protocols | en |
| dc.subject | Vibrio cholerae | en |
| dc.subject | Adenovirus Vaccines | en |
| dc.subject | Bangladesh | en |
| dc.title | Phase I safety and immunogenicity studies of Peru 15, a live attenuated oral vaccine candidate for Vibrio cholerae 01 in Bangladeshi volunteers, both adults and children | en |
| dc.type | Other | en |
| Appears in Collections: | Laboratory sciences research protocols | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ICDDRBProtocol-2000-027.pdf | 2.66 MB | Adobe PDF | View/Open |
This item is protected by original copyright |